S Rotstein

960 total citations
34 papers, 752 citations indexed

About

S Rotstein is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, S Rotstein has authored 34 papers receiving a total of 752 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 12 papers in Cancer Research and 11 papers in Genetics. Recurrent topics in S Rotstein's work include Estrogen and related hormone effects (9 papers), Breast Cancer Treatment Studies (9 papers) and Cancer Treatment and Pharmacology (6 papers). S Rotstein is often cited by papers focused on Estrogen and related hormone effects (9 papers), Breast Cancer Treatment Studies (9 papers) and Cancer Treatment and Pharmacology (6 papers). S Rotstein collaborates with scholars based in Sweden, United Kingdom and France. S Rotstein's co-authors include L. E. Rutqvist, R. Arriagada, A Mattsson, Henric Blomgren, A. Kramar, Lambert Skoog, J. Wasserman, B Petrini, Annika Lindblom and Catharina Larsson and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

S Rotstein

32 papers receiving 714 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Rotstein Sweden 13 387 341 208 195 114 34 752
G G Ribeiro United Kingdom 17 320 0.8× 255 0.7× 169 0.8× 309 1.6× 79 0.7× 26 850
Cha Kyong Yom South Korea 15 220 0.6× 143 0.4× 166 0.8× 102 0.5× 136 1.2× 23 583
Anne O’Dea United States 14 233 0.6× 445 1.3× 133 0.6× 106 0.5× 54 0.5× 45 716
V. Valero United States 11 339 0.9× 456 1.3× 116 0.6× 85 0.4× 66 0.6× 33 708
Hector Arango United States 10 221 0.6× 329 1.0× 106 0.5× 373 1.9× 206 1.8× 15 1.2k
J. Durand France 10 460 1.2× 341 1.0× 239 1.1× 228 1.2× 96 0.8× 31 796
K Fischerman Denmark 11 131 0.3× 192 0.6× 55 0.3× 95 0.5× 134 1.2× 23 480
Sven J. Kister United States 16 270 0.7× 263 0.8× 198 1.0× 48 0.2× 392 3.4× 20 854
A. Rodger United Kingdom 12 322 0.8× 292 0.9× 150 0.7× 99 0.5× 111 1.0× 28 520
A. Norgren Sweden 14 126 0.3× 126 0.4× 75 0.4× 148 0.8× 92 0.8× 42 680

Countries citing papers authored by S Rotstein

Since Specialization
Citations

This map shows the geographic impact of S Rotstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Rotstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Rotstein more than expected).

Fields of papers citing papers by S Rotstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Rotstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Rotstein. The network helps show where S Rotstein may publish in the future.

Co-authorship network of co-authors of S Rotstein

This figure shows the co-authorship network connecting the top 25 collaborators of S Rotstein. A scholar is included among the top collaborators of S Rotstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Rotstein. S Rotstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hatschek, Thomas, Lena Carlsson, Zakaria Einbeigi, et al.. (2011). Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial. Breast Cancer Research and Treatment. 131(3). 939–947. 23 indexed citations
2.
Leifland, Karin, et al.. (2010). Prevention of tumour cell dissemination in diagnostic needle procedures. British Journal of Cancer. 103(11). 1706–1709. 21 indexed citations
3.
Sverrisdóttir, Ásgerður, Hemming Johansson, Unn‐Britt Johansson, et al.. (2010). Abstract S1-5: Interaction between Goserelin and Tamoxifen in a Controlled Clinical Trial of Adjuvant Endocrine Therapy in Premenopausal Breast Cancer.. Cancer Research. 70(24_Supplement). S1–5. 4 indexed citations
4.
Ljungman, Per, Bo Björkstrand, Tommy� Fornander, et al.. (1998). High-dose chemotherapy with autologous stem cell support in patients with responding stage IV breast cancer. Bone Marrow Transplantation. 22(5). 445–448. 9 indexed citations
5.
Nilsson, Bo, Timo Hakulinen, Tiiu Aareleid, et al.. (1997). Cancer survival in Estonian migrants to Sweden.. Journal of Epidemiology & Community Health. 51(4). 418–423. 10 indexed citations
6.
Arriagada, R., L. E. Rutqvist, A Mattsson, A. Kramar, & S Rotstein. (1995). Adequate locoregional treatment for early breast cancer may prevent secondary dissemination.. Journal of Clinical Oncology. 13(12). 2869–2878. 162 indexed citations
7.
Fredrikson, M, Carl Johan Fürst, Mats Lekander, S Rotstein, & Henric Blomgren. (1993). Trait Anxiety and Anticipatory Immune Reactions in Women Receiving Adjuvant Chemotherapy for Breast Cancer. Brain Behavior and Immunity. 7(1). 79–90. 30 indexed citations
8.
Blomgren, Henric, Ulla Glas, Bengt‐Olof Nilsson, et al.. (1993). BLOOD LYMPHOCYTE SUBSETS IN OPERABLE BREAST-CANCER - RELATION TO EXTENT OF TUMOR DISEASE AND PROGNOSIS. International Journal of Oncology. 2(4). 627–32.
9.
Lindblom, Annika, S Rotstein, Magnus Nordenskjöld, & Catharina Larsson. (1993). Linkage analysis with markers on 17q in 29 Swedish breast cancer families.. PubMed. 52(4). 749–53. 11 indexed citations
10.
Auquier, Ariane, L. E. Rutqvist, S Rotstein, Herman Høst, & R. Arriagada. (1992). Post-mastectomy megavoltage radiotherapy: The Oslo and Stockholm trials. European Journal of Cancer. 28(2-3). 433–437. 69 indexed citations
11.
Rutqvist, L. E., Björn Cedermark, Ulla Glas, et al.. (1991). Contralateral Primary Tumors in Breast Cancer Patients in a Randomized Trial of Adjuvant Tamoxifen Therapy. JNCI Journal of the National Cancer Institute. 83(18). 1299–1306. 113 indexed citations
12.
Rutqvist, Lars Erik, Björn Cedermark, Tommy� Fornander, et al.. (1989). The relationship between hormone receptor content and the effect of adjuvant tamoxifen in operable breast cancer.. Journal of Clinical Oncology. 7(10). 1474–1484. 36 indexed citations
13.
14.
Rotstein, S, et al.. (1989). Long-Term Follow-Up of Sickness Periods in Breast Cancer Patients Primarily Treated with Surgery and Radiotherapy Or Surgery Only. Acta Oncologica. 28(6). 817–822. 5 indexed citations
15.
Rotstein, S, Henric Blomgren, Edward Baral, et al.. (1987). Incidence of Infectious Symptoms after Radiation Therapy for Breast Cancer: Long-term effects. Acta Oncologica. 26(3). 197–201. 10 indexed citations
16.
Baral, Edward, et al.. (1986). Effect of tamoxifen on pokeweed mitogen stimulated immunoglobulin secretion in vitro.. PubMed. 21(3). 137–9. 15 indexed citations
17.
Rotstein, S, et al.. (1985). Long-term effects on the immune system following local irradiation for breast cancer. Pokeweed mitogen induced immunoglobulin secretion by blood lymphocytes and serum immunoglobulin levels.. PubMed. 11(2). 137–41. 8 indexed citations
18.
Petrini, B, J. Wasserman, Henric Blomgren, & S Rotstein. (1984). Changes of blood T cell subsets in patients receiving postoperative adjuvant chemotherapy for breast cancer. European Journal of Cancer and Clinical Oncology. 20(12). 1485–1487. 5 indexed citations
19.
Petrini, B, J. Wasserman, Henric Blomgren, & S Rotstein. (1983). T helper/suppressor ratios in chemotherapy and radiotherapy.. PubMed. 53(1). 255–6. 17 indexed citations
20.
Rotstein, S, Edward Baral, Henric Blomgren, & B. Johansson. (1983). In vitro radiosensitivity of the spontaneous cytotoxicity of blood lymphocytes in patients with untreated Hodgkin's disease. European Journal of Cancer and Clinical Oncology. 19(10). 1405–1409. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G G Ribeiro Breakdown of academic impact, for papers by Cha Kyong Yom Breakdown of academic impact, for papers by Anne O’Dea Breakdown of academic impact, for papers by V. Valero Breakdown of academic impact, for papers by Hector Arango Breakdown of academic impact, for papers by J. Durand Breakdown of academic impact, for papers by K Fischerman Breakdown of academic impact, for papers by Sven J. Kister Breakdown of academic impact, for papers by A. Rodger Breakdown of academic impact, for papers by A. Norgren
Rankless by CCL
2026